The Hematocrit Testing Market is poised for significant growth, with its valuation increasing from USD 1.63 billion in 2023 to an estimated USD 2.63 billion by 2032, reflecting a compound annual growth rate (CAGR) of 5.47%. This expansion is fueled by the rising prevalence of anemia, blood-related disorders, and the growing adoption of point-of-care hematocrit testing devices....